![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 42, 32708-32715, October 20, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Diabetes Unit, Centre Médical Universitaire,
1211 Genève 4, Switzerland
Glucagon gene expression is controlled by at
least four DNA elements within the promoter; G2, G3, and G4 confer
islet-specific expression, while G1 restricts glucagon transcription to
cells. Two islet-specific complexes are formed on G3, the
insulin-responsive element of the glucagon gene; one of these
corresponds to the paired homeodomain protein Pax-6, a major glucagon
gene transactivator that plays a crucial role in
cell development.
We describe here the identification of the second complex as Pax-2,
another member of the paired box family. Pax-2 is known to be crucial
for the development of the urogenital tract and of the central nervous system, but its presence in the endocrine pancreas has not been reported. We detected Pax-2 gene expression by RT-PCR; in islets, Pax-2
is present as two alternative splicing isoforms, Pax-2A and Pax-2B,
whereas in the glucagon- and insulin-producing cell lines
TC1 and
Min6, a distinct isoform, Pax-2D2, is found in addition to Pax-2B. Both
islet-specific isoforms bind to the enhancer element G3 and to the
-specific promoter element G1 that also interacts with Pax-6. Pax-2A
and Pax-2B dose-dependently activate transcription from the
G3 and the G1 elements both in heterologous and in glucagon-producing
cells. Our data indicate that Pax-2 is the third paired domain protein
present in the endocrine pancreas and that one of its roles may be the
regulation of glucagon gene expression.
To whom correspondence should be addressed. Tel.: 41-22-702-55-67;
Fax: 41-22-702-55-43; E-mail: Beate.Laser@medecine.unige.ch.
This article has been cited by other articles:
![]() |
T. Jin Mechanisms underlying proglucagon gene expression J. Endocrinol., July 1, 2008; 198(1): 17 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fletcher, M. Hu, Y. Berman, F. Collins, J. Grigg, M. McIver, H. Juppner, and S. I. Alexander Multicystic Dysplastic Kidney and Variable Phenotype in a Family with a Novel Deletion Mutation of PAX2 J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2754 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maziarz, C. Chung, D. J. Drucker, and A. Emili Integrating Global Proteomic and Genomic Expression Profiles Generated from Islet {alpha} Cells: Opportunities and Challenges to Deriving Reliable Biological Inferences Mol. Cell. Proteomics, April 1, 2005; 4(4): 458 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K.Y. Trinh, K. Zhang, M. Hossain, P. L. Brubaker, and D. J. Drucker Pax-6 Activates Endogenous Proglucagon Gene Expression in the Rodent Gastrointestinal Epithelium Diabetes, February 1, 2003; 52(2): 425 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ni, Y. Anini, X. Fang, G. Mills, P. L Brubaker, and T. Jin Transcriptional Activation of the Proglucagon Gene by Lithium and beta -Catenin in Intestinal Endocrine L Cells J. Biol. Chem., January 3, 2003; 278(2): 1380 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Flock and D. J. Drucker Pax-2 Activates the Proglucagon Gene Promoter But Is Not Essential for Proglucagon Gene Expression or Development of Proglucagon-Producing Cell Lineages in the Murine Pancreas or Intestine Mol. Endocrinol., October 1, 2002; 16(10): 2349 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoffmeister, A. Ropolo, S. Vasseur, G. V. Mallo, H. Bodeker, B. Ritz-Laser, G. R. Dressler, M. I. Vaccaro, J.-C. Dagorn, S. Moreno, et al. The HMG-I/Y-related Protein p8 Binds to p300 and Pax2 trans-Activation Domain-interacting Protein to Regulate the trans-Activation Activity of the Pax2A and Pax2B Transcription Factors on the Glucagon Gene Promoter J. Biol. Chem., June 14, 2002; 277(25): 22314 - 22319. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Gauthier, V. M. Schwitzgebel, M. Zaiko, A. Mamin, B. Ritz-Laser, and J. Philippe Hepatic Nuclear Factor-3 (HNF-3 or Foxa2) Regulates Glucagon Gene Transcription by Binding to the G1 and G2 Promoter Elements Mol. Endocrinol., January 1, 2002; 16(1): 170 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Planque, L. Leconte, F. M. Coquelle, S. Benkhelifa, P. Martin, M.-P. Felder-Schmittbuhl, and S. Saule Interaction of Maf Transcription Factors with Pax-6 Results in Synergistic Activation of the Glucagon Promoter J. Biol. Chem., September 14, 2001; 276(38): 35751 - 35760. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |